Frequencies for first 10,000 rows of indi_pt variable in indi2016q1 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- Abdominal discomfort | 28 0.28 0.28 Abdominal distension | 1 0.01 0.29 Abdominal infection | 2 0.02 0.31 Abdominal pain | 9 0.09 0.40 Abdominal pain upper | 1 0.01 0.41 Abnormal behaviour | 4 0.04 0.45 Acidosis | 2 0.02 0.47 Acne | 23 0.23 0.70 Acne cystic | 1 0.01 0.71 Acquired immunodeficiency syndrome | 1 0.01 0.72 Acquired oesophageal web | 3 0.03 0.75 Acral overgrowth | 1 0.01 0.76 Acromegaly | 3 0.03 0.79 Acute coronary syndrome | 3 0.03 0.82 Acute graft versus host disease | 9 0.09 0.91 Acute hepatitis B | 1 0.01 0.92 Acute leukaemia | 6 0.06 0.98 Acute lymphocytic leukaemia | 4 0.04 1.02 Acute myeloid leukaemia | 35 0.35 1.37 Acute psychosis | 1 0.01 1.38 Addison's disease | 6 0.06 1.44 Adenocarcinoma | 5 0.05 1.49 Adenocarcinoma gastric | 1 0.01 1.50 Adenocarcinoma of colon | 3 0.03 1.53 Adjuvant therapy | 1 0.01 1.54 Adrenal gland cancer | 1 0.01 1.55 Adrenal insufficiency | 1 0.01 1.56 Adrenocortical carcinoma | 5 0.05 1.61 Adult T-cell lymphoma/leukaemia | 1 0.01 1.62 Adverse event | 3 0.03 1.65 Affect lability | 11 0.11 1.76 Affective disorder | 9 0.09 1.85 Age-related macular degeneration | 4 0.04 1.89 Aggression | 2 0.02 1.91 Agitation | 2 0.02 1.93 Akathisia | 1 0.01 1.94 Alagille syndrome | 5 0.05 1.99 Alcohol abuse | 6 0.06 2.05 Alcoholism | 2 0.02 2.07 Alopecia | 34 0.34 2.41 Alopecia areata | 1 0.01 2.42 Altered state of consciousness | 1 0.01 2.43 Amniotic cavity infection | 1 0.01 2.44 Anaemia | 11 0.11 2.55 Anaemia of malignant disease | 1 0.01 2.56 Anaemia prophylaxis | 1 0.01 2.57 Anaesthesia | 1 0.01 2.58 Analgesic therapy | 1 0.01 2.59 Anaplastic astrocytoma | 2 0.02 2.61 Androgenetic alopecia | 22 0.22 2.83 Aneurysm | 1 0.01 2.84 Anger | 1 0.01 2.85 Angina pectoris | 11 0.11 2.96 Angiomyolipoma | 1 0.01 2.97 Angiopathy | 2 0.02 2.99 Angiotensin converting enzyme | 1 0.01 3.00 Ankylosing spondylitis | 19 0.19 3.19 Anovulatory cycle | 1 0.01 3.20 Antacid therapy | 1 0.01 3.21 Antiallergic therapy | 2 0.02 3.23 Antibiotic prophylaxis | 9 0.09 3.32 Antibiotic therapy | 5 0.05 3.37 Anticoagulant therapy | 15 0.15 3.52 Antidepressant therapy | 2 0.02 3.54 Antifungal prophylaxis | 5 0.05 3.59 Antiinflammatory therapy | 1 0.01 3.60 Antiretroviral therapy | 16 0.16 3.76 Antiviral prophylaxis | 3 0.03 3.79 Anxiety | 82 0.82 4.61 Anxiety disorder | 4 0.04 4.65 Anxiolytic therapy | 3 0.03 4.68 Aortic calcification | 1 0.01 4.69 Aortic stenosis | 1 0.01 4.70 Aortic valve replacement | 1 0.01 4.71 Aplasia | 1 0.01 4.72 Aplasia pure red cell | 3 0.03 4.75 Aplastic anaemia | 15 0.15 4.90 Arrhythmia | 4 0.04 4.94 Arrhythmia prophylaxis | 2 0.02 4.96 Arterial disorder | 1 0.01 4.97 Arterial occlusive disease | 1 0.01 4.98 Arterial spasm | 1 0.01 4.99 Arteriosclerosis | 4 0.04 5.03 Arthralgia | 12 0.12 5.15 Arthritis | 29 0.29 5.44 Arthropathy | 1 0.01 5.45 Asthenia | 3 0.03 5.48 Asthma | 126 1.26 6.74 Astrocytoma | 1 0.01 6.75 Atherosclerosis prophylaxis | 2 0.02 6.77 Atrial fibrillation | 38 0.38 7.15 Atrioventricular block | 1 0.01 7.16 Attention deficit/hyperactivity disor.. | 5 0.05 7.21 Autism | 3 0.03 7.24 Autism spectrum disorder | 1 0.01 7.25 Autoimmune disorder | 1 0.01 7.26 Autoinflammatory disease | 4 0.04 7.30 Axillary mass | 1 0.01 7.31 B-cell lymphoma | 28 0.28 7.59 Back injury | 1 0.01 7.60 Back pain | 26 0.26 7.86 Balance disorder | 1 0.01 7.87 Barrett's oesophagus | 13 0.13 8.00 Basal cell carcinoma | 2 0.02 8.02 Behcet's syndrome | 8 0.08 8.10 Benign prostatic hyperplasia | 10 0.10 8.20 Bipolar I disorder | 10 0.10 8.30 Bipolar II disorder | 1 0.01 8.31 Bipolar disorder | 162 1.62 9.93 Bladder disorder | 3 0.03 9.96 Blood alkaline phosphatase increased | 1 0.01 9.97 Blood calcium | 1 0.01 9.98 Blood cholesterol | 8 0.08 10.06 Blood cholesterol abnormal | 46 0.46 10.52 Blood cholesterol increased | 66 0.66 11.18 Blood corticotrophin decreased | 1 0.01 11.19 Blood cortisol abnormal | 2 0.02 11.21 Blood disorder | 1 0.01 11.22 Blood follicle stimulating hormone de.. | 1 0.01 11.23 Blood glucose decreased | 1 0.01 11.24 Blood glucose increased | 4 0.04 11.28 Blood growth hormone | 1 0.01 11.29 Blood iron increased | 1 0.01 11.30 Blood luteinising hormone decreased | 1 0.01 11.31 Blood parathyroid hormone increased | 2 0.02 11.33 Blood phosphorus increased | 1 0.01 11.34 Blood potassium abnormal | 1 0.01 11.35 Blood potassium decreased | 2 0.02 11.37 Blood pressure abnormal | 26 0.26 11.63 Blood pressure increased | 3 0.03 11.66 Blood pressure management | 1 0.01 11.67 Blood pressure measurement | 12 0.12 11.79 Blood sodium decreased | 1 0.01 11.80 Blood triglycerides abnormal | 3 0.03 11.83 Blood triglycerides increased | 14 0.14 11.97 Blood viscosity increased | 1 0.01 11.98 Body height below normal | 1 0.01 11.99 Bone cancer | 2 0.02 12.01 Bone density abnormal | 1 0.01 12.02 Bone disorder | 14 0.14 12.16 Bone marrow conditioning regimen | 5 0.05 12.21 Bone marrow disorder | 1 0.01 12.22 Bone marrow failure | 1 0.01 12.23 Bone pain | 1 0.01 12.24 Borderline personality disorder | 4 0.04 12.28 Bowel movement irregularity | 2 0.02 12.30 Brain neoplasm benign | 1 0.01 12.31 Breakthrough pain | 9 0.09 12.40 Breast cancer | 91 0.91 13.31 Breast cancer metastatic | 9 0.09 13.40 Breast cancer recurrent | 2 0.02 13.42 Bronchial carcinoma | 3 0.03 13.45 Bronchial obstruction | 1 0.01 13.46 Bronchitis | 15 0.15 13.61 Bronchitis chronic | 4 0.04 13.65 Burkitt's lymphoma | 36 0.36 14.01 Burning sensation | 1 0.01 14.02 Bursitis | 1 0.01 14.03 Calcium deficiency | 3 0.03 14.06 Calcium metabolism disorder | 1 0.01 14.07 Cancer pain | 1 0.01 14.08 Candida infection | 1 0.01 14.09 Candida sepsis | 2 0.02 14.11 Carcinoid syndrome | 2 0.02 14.13 Carcinoid tumour | 2 0.02 14.15 Carcinoid tumour of the stomach | 1 0.01 14.16 Cardiac disorder | 30 0.30 14.46 Cardiac failure | 23 0.23 14.69 Cardiac failure chronic | 4 0.04 14.73 Cardiac failure congestive | 1 0.01 14.74 Cardiac operation | 4 0.04 14.78 Cardiac valve disease | 1 0.01 14.79 Cardiotoxicity | 3 0.03 14.82 Cardiovascular disorder | 1 0.01 14.83 Cardiovascular event prophylaxis | 5 0.05 14.88 Cardiovascular insufficiency | 1 0.01 14.89 Carpal tunnel syndrome | 1 0.01 14.90 Catheter management | 1 0.01 14.91 Cerebral disorder | 5 0.05 14.96 Cerebral infarction | 3 0.03 14.99 Cerebral ischaemia | 4 0.04 15.03 Cerebrovascular accident | 7 0.07 15.10 Cerebrovascular accident prophylaxis | 5 0.05 15.15 Cervical myelopathy | 3 0.03 15.18 Cervicobrachial syndrome | 1 0.01 15.19 Cervix carcinoma | 18 0.18 15.37 Chalazion | 2 0.02 15.39 Cheilitis | 3 0.03 15.42 Chemotherapy | 12 0.12 15.54 Chest pain | 14 0.14 15.68 Cholangiocarcinoma | 2 0.02 15.70 Cholangitis | 6 0.06 15.76 Choroidal neovascularisation | 1 0.01 15.77 Chronic gastritis | 2 0.02 15.79 Chronic hepatitis B | 19 0.19 15.98 Chronic hepatitis C | 29 0.29 16.27 Chronic lymphocytic leukaemia | 6 0.06 16.33 Chronic myeloid leukaemia | 41 0.41 16.74 Chronic myeloid leukaemia transformat.. | 1 0.01 16.75 Chronic obstructive pulmonary disease | 66 0.66 17.41 Clear cell sarcoma of soft tissue | 1 0.01 17.42 Cluster headache | 1 0.01 17.43 Coagulation time prolonged | 1 0.01 17.44 Colitis | 5 0.05 17.49 Colitis ulcerative | 86 0.86 18.35 Colon cancer | 1 0.01 18.36 Colorectal cancer | 4 0.04 18.40 Colorectal cancer metastatic | 3 0.03 18.43 Congenital cytomegalovirus infection | 2 0.02 18.45 Connective tissue disorder | 1 0.01 18.46 Constipation | 30 0.30 18.76 Constipation prophylaxis | 3 0.03 18.79 Contraception | 57 0.57 19.36 Contrast media allergy | 1 0.01 19.37 Convulsion prophylaxis | 1 0.01 19.38 Cor pulmonale chronic | 5 0.05 19.43 Coronary artery disease | 8 0.08 19.51 Cough | 6 0.06 19.57 Crohn's disease | 39 0.39 19.96 Crying | 1 0.01 19.97 Cryopyrin associated periodic syndrome | 3 0.03 20.00 Cryptococcosis | 4 0.04 20.04 Cystic fibrosis | 16 0.16 20.20 Cystitis | 8 0.08 20.28 Cytomegalovirus colitis | 1 0.01 20.29 Cytomegalovirus infection | 1 0.01 20.30 Decreased appetite | 2 0.02 20.32 Decubitus ulcer | 1 0.01 20.33 Deep vein thrombosis | 10 0.10 20.43 Dehydration | 1 0.01 20.44 Delirium | 3 0.03 20.47 Delusion | 5 0.05 20.52 Delusional perception | 1 0.01 20.53 Dementia | 5 0.05 20.58 Dementia Alzheimer's type | 10 0.10 20.68 Demyelinating polyneuropathy | 1 0.01 20.69 Depersonalisation/derealisation disor.. | 1 0.01 20.70 Depressed mood | 1 0.01 20.71 Depression | 134 1.34 22.05 Depressive symptom | 10 0.10 22.15 Derealisation | 1 0.01 22.16 Dermatitis allergic | 1 0.01 22.17 Dermatitis contact | 1 0.01 22.18 Device related infection | 2 0.02 22.20 Diabetes mellitus | 109 1.09 23.29 Diabetes mellitus inadequate control | 5 0.05 23.34 Diabetes mellitus management | 1 0.01 23.35 Diabetic eye disease | 1 0.01 23.36 Diabetic neuropathy | 2 0.02 23.38 Diabetic retinal oedema | 1 0.01 23.39 Diabetic retinopathy | 1 0.01 23.40 Dialysis | 2 0.02 23.42 Diarrhoea | 19 0.19 23.61 Diffuse large B-cell lymphoma | 58 0.58 24.19 Disseminated intravascular coagulation | 1 0.01 24.20 Disseminated tuberculosis | 10 0.10 24.30 Dissociative disorder | 1 0.01 24.31 Dissociative identity disorder | 1 0.01 24.32 Disturbance in attention | 1 0.01 24.33 Diuretic therapy | 4 0.04 24.37 Diverticulitis | 3 0.03 24.40 Dizziness | 1 0.01 24.41 Drug dependence | 1 0.01 24.42 Drug effect decreased | 1 0.01 24.43 Drug eruption | 2 0.02 24.45 Drug therapy | 1 0.01 24.46 Drug withdrawal syndrome | 1 0.01 24.47 Dry eye | 4 0.04 24.51 Dry skin | 1 0.01 24.52 Duchenne muscular dystrophy | 1 0.01 24.53 Dyslipidaemia | 9 0.09 24.62 Dysmenorrhoea | 3 0.03 24.65 Dyspepsia | 27 0.27 24.92 Dysphagia | 1 0.01 24.93 Dyspnoea | 9 0.09 25.02 Dystonia | 1 0.01 25.03 Dysuria | 2 0.02 25.05 Eczema infantile | 2 0.02 25.07 Electrolyte imbalance | 1 0.01 25.08 Electrolyte substitution therapy | 1 0.01 25.09 Embolism | 1 0.01 25.10 Embryonal rhabdomyosarcoma | 6 0.06 25.16 Emphysema | 7 0.07 25.23 Endometrial cancer | 1 0.01 25.24 Endometriosis | 3 0.03 25.27 Endoscopy gastrointestinal | 3 0.03 25.30 Enterocolitis | 5 0.05 25.35 Epidural analgesia | 2 0.02 25.37 Epigastric discomfort | 2 0.02 25.39 Epilepsy | 39 0.39 25.78 Epstein-Barr virus infection | 6 0.06 25.84 Erectile dysfunction | 1 0.01 25.85 Erosive oesophagitis | 3 0.03 25.88 Eructation | 1 0.01 25.89 Erysipelas | 2 0.02 25.91 Erythema | 1 0.01 25.92 Essential hypertension | 3 0.03 25.95 Euphoric mood | 1 0.01 25.96 Ewing's sarcoma | 4 0.04 26.00 Ewing's sarcoma metastatic | 4 0.04 26.04 Ex-tobacco user | 1 0.01 26.05 Exposure during pregnancy | 1 0.01 26.06 Extrapyramidal disorder | 4 0.04 26.10 Eye infection viral | 2 0.02 26.12 Eye irritation | 1 0.01 26.13 Eye pain | 1 0.01 26.14 Factor V Leiden mutation | 1 0.01 26.15 Faecal elastase concentration abnormal | 1 0.01 26.16 Faeces hard | 1 0.01 26.17 Familial mediterranean fever | 2 0.02 26.19 Fatigue | 3 0.03 26.22 Feeling abnormal | 1 0.01 26.23 Feeling cold | 1 0.01 26.24 Feeling of relaxation | 2 0.02 26.26 Fibromyalgia | 17 0.17 26.43 Flatulence | 2 0.02 26.45 Fluid imbalance | 1 0.01 26.46 Fluid replacement | 2 0.02 26.48 Fluid retention | 12 0.12 26.60 Foetal exposure during pregnancy | 2 0.02 26.62 Folate deficiency | 1 0.01 26.63 Fracture | 1 0.01 26.64 Fungaemia | 1 0.01 26.65 Fungal infection | 2 0.02 26.67 Gait disturbance | 1 0.01 26.68 Gallbladder pain | 2 0.02 26.70 Gastric cancer | 21 0.21 26.91 Gastric disorder | 5 0.05 26.96 Gastric pH decreased | 1 0.01 26.97 Gastric ulcer | 5 0.05 27.02 Gastritis | 7 0.07 27.09 Gastritis prophylaxis | 8 0.08 27.17 Gastroduodenal ulcer | 1 0.01 27.18 Gastrointestinal carcinoma | 2 0.02 27.20 Gastrointestinal disorder | 6 0.06 27.26 Gastrointestinal motility disorder | 1 0.01 27.27 Gastrointestinal pain | 1 0.01 27.28 Gastrooesophageal reflux disease | 149 1.49 28.77 General physical health deterioration | 1 0.01 28.78 Generalised tonic-clonic seizure | 1 0.01 28.79 Genital neoplasm malignant female | 1 0.01 28.80 Gestational diabetes | 10 0.10 28.90 Gestational hypertension | 1 0.01 28.91 Gestational trophoblastic tumour | 37 0.37 29.28 Gingival bleeding | 1 0.01 29.29 Gingivitis | 4 0.04 29.33 Glaucoma | 10 0.10 29.43 Glioblastoma | 4 0.04 29.47 Glioma | 1 0.01 29.48 Glossitis | 1 0.01 29.49 Glucose tolerance impaired | 3 0.03 29.52 Glucose tolerance impaired in pregnancy | 4 0.04 29.56 Glycosylated haemoglobin increased | 1 0.01 29.57 Goitre | 2 0.02 29.59 Gout | 6 0.06 29.65 Graft versus host disease | 2 0.02 29.67 Grandiosity | 1 0.01 29.68 Granuloma | 2 0.02 29.70 Granulomatosis with polyangiitis | 3 0.03 29.73 Growth hormone deficiency | 1 0.01 29.74 Growth retardation | 1 0.01 29.75 HER-2 positive breast cancer | 15 0.15 29.90 HIV infection | 192 1.92 31.82 Haemolytic uraemic syndrome | 1 0.01 31.83 Haemophilus test positive | 2 0.02 31.85 Haemoptysis | 1 0.01 31.86 Haemorrhage | 1 0.01 31.87 Haemorrhoids | 3 0.03 31.90 Hair disorder | 1 0.01 31.91 Hallucination | 4 0.04 31.95 Hallucination, auditory | 2 0.02 31.97 Hallucinations, mixed | 1 0.01 31.98 Head titubation | 1 0.01 31.99 Headache | 28 0.28 32.27 Heart rate abnormal | 2 0.02 32.29 Heart rate increased | 1 0.01 32.30 Heart rate irregular | 3 0.03 32.33 Heart transplant | 3 0.03 32.36 Heart valve incompetence | 1 0.01 32.37 Helicobacter infection | 13 0.13 32.50 Heparin-induced thrombocytopenia | 2 0.02 32.52 Hepatic cancer | 7 0.07 32.59 Hepatic cirrhosis | 2 0.02 32.61 Hepatitis B | 22 0.22 32.83 Hepatitis C | 21 0.21 33.04 Hepatitis D | 1 0.01 33.05 Hepatitis viral | 1 0.01 33.06 Hepatocellular carcinoma | 7 0.07 33.13 Hernia | 3 0.03 33.16 Herpes simplex | 3 0.03 33.19 Herpes zoster | 6 0.06 33.25 Hiatus hernia | 7 0.07 33.32 Hiccups | 1 0.01 33.33 Histiocytosis haematophagic | 6 0.06 33.39 Hormone replacement therapy | 7 0.07 33.46 Hormone therapy | 4 0.04 33.50 Hot flush | 1 0.01 33.51 Human immunodeficiency virus transmis.. | 3 0.03 33.54 Hyper IgD syndrome | 1 0.01 33.55 Hyperbilirubinaemia | 1 0.01 33.56 Hypercalcaemia | 1 0.01 33.57 Hypercholesterolaemia | 21 0.21 33.78 Hyperglycaemia | 1 0.01 33.79 Hyperkinesia | 1 0.01 33.80 Hyperlipidaemia | 22 0.22 34.02 Hyperparathyroidism secondary | 2 0.02 34.04 Hyperphosphataemia | 3 0.03 34.07 Hypersensitivity | 13 0.13 34.20 Hypertension | 211 2.11 36.31 Hyperthermia | 1 0.01 36.32 Hyperthyroidism | 1 0.01 36.33 Hypertonic bladder | 2 0.02 36.35 Hypertriglyceridaemia | 1 0.01 36.36 Hypertrophic cardiomyopathy | 2 0.02 36.38 Hyperuricaemia | 5 0.05 36.43 Hypoaesthesia | 1 0.01 36.44 Hypocalcaemia | 1 0.01 36.45 Hypoglycaemia | 1 0.01 36.46 Hypogonadism | 1 0.01 36.47 Hypokalaemia | 5 0.05 36.52 Hypomagnesaemia | 1 0.01 36.53 Hypomania | 1 0.01 36.54 Hyponatraemia | 1 0.01 36.55 Hypopituitarism | 4 0.04 36.59 Hypothyroidism | 33 0.33 36.92 Hypotonia | 1 0.01 36.93 Hypovitaminosis | 4 0.04 36.97 Hypovolaemia | 1 0.01 36.98 Ill-defined disorder | 13 0.13 37.11 Immune system disorder | 1 0.01 37.12 Immune thrombocytopenic purpura | 13 0.13 37.25 Immunisation | 1 0.01 37.26 Immunoglobulin therapy | 1 0.01 37.27 Immunosuppressant drug therapy | 10 0.10 37.37 Immunosuppression | 11 0.11 37.48 Impulsive behaviour | 1 0.01 37.49 Incontinence | 1 0.01 37.50 Infection | 5 0.05 37.55 Infection prophylaxis | 3 0.03 37.58 Infertility | 3 0.03 37.61 Inflammation | 4 0.04 37.65 Inflammatory bowel disease | 18 0.18 37.83 Influenza | 3 0.03 37.86 Influenza like illness | 1 0.01 37.87 Infusion related reaction | 2 0.02 37.89 Inhalation therapy | 4 0.04 37.93 Insomnia | 53 0.53 38.46 Insulin-requiring type 2 diabetes mel.. | 3 0.03 38.49 Intellectual disability | 3 0.03 38.52 International normalised ratio increa.. | 1 0.01 38.53 Interstitial lung disease | 4 0.04 38.57 Intervertebral disc degeneration | 4 0.04 38.61 Intervertebral disc disorder | 1 0.01 38.62 Intervertebral disc protrusion | 3 0.03 38.65 Intestinal haemorrhage | 1 0.01 38.66 Intraductal proliferative breast lesion | 1 0.01 38.67 Intraocular pressure increased | 1 0.01 38.68 Invasive breast carcinoma | 4 0.04 38.72 Invasive ductal breast carcinoma | 1 0.01 38.73 Iron deficiency | 1 0.01 38.74 Iron deficiency anaemia | 4 0.04 38.78 Iron overload | 17 0.17 38.95 Irritability | 1 0.01 38.96 Irritable bowel syndrome | 7 0.07 39.03 Ischaemic cardiomyopathy | 1 0.01 39.04 Ischaemic heart disease prophylaxis | 2 0.02 39.06 Ischaemic stroke | 5 0.05 39.11 Jejunal ulcer | 2 0.02 39.13 Joint injury | 1 0.01 39.14 Juvenile idiopathic arthritis | 13 0.13 39.27 Laryngeal cancer | 1 0.01 39.28 Learning disability | 1 0.01 39.29 Leprosy | 1 0.01 39.30 Leukaemia | 3 0.03 39.33 Lichen planus | 1 0.01 39.34 Lip and/or oral cavity cancer | 2 0.02 39.36 Lip pain | 1 0.01 39.37 Lipids increased | 1 0.01 39.38 Listeriosis | 3 0.03 39.41 Liver disorder | 1 0.01 39.42 Liver transplant | 2 0.02 39.44 Logorrhoea | 1 0.01 39.45 Low density lipoprotein | 4 0.04 39.49 Low density lipoprotein increased | 4 0.04 39.53 Lower respiratory tract infection | 1 0.01 39.54 Lower respiratory tract infection bac.. | 1 0.01 39.55 Lumbar radiculopathy | 1 0.01 39.56 Lumbar spinal stenosis | 1 0.01 39.57 Lung adenocarcinoma | 5 0.05 39.62 Lung adenocarcinoma metastatic | 1 0.01 39.63 Lung adenocarcinoma stage IV | 1 0.01 39.64 Lung disorder | 4 0.04 39.68 Lung infiltration | 1 0.01 39.69 Lung neoplasm malignant | 8 0.08 39.77 Lung transplant | 6 0.06 39.83 Lupus nephritis | 6 0.06 39.89 Lymphocytic lymphoma | 3 0.03 39.92 Lymphoma | 1 0.01 39.93 Macular degeneration | 2 0.02 39.95 Macular hole | 1 0.01 39.96 Major depression | 18 0.18 40.14 Malignant ascites | 4 0.04 40.18 Malignant glioma | 2 0.02 40.20 Malignant hypertension | 2 0.02 40.22 Malignant melanoma | 16 0.16 40.38 Malignant melanoma of eyelid | 1 0.01 40.39 Malignant neoplasm of ampulla of Vater | 1 0.01 40.40 Malignant respiratory tract neoplasm | 5 0.05 40.45 Mania | 5 0.05 40.50 Mantle cell lymphoma | 10 0.10 40.60 Maternal exposure during pregnancy | 1 0.01 40.61 Medication dilution | 1 0.01 40.62 Medullary thyroid cancer | 5 0.05 40.67 Memory impairment | 1 0.01 40.68 Meningitis | 7 0.07 40.75 Menopausal disorder | 1 0.01 40.76 Menopause | 4 0.04 40.80 Menorrhagia | 1 0.01 40.81 Menstrual cycle management | 3 0.03 40.84 Mental disorder | 1 0.01 40.85 Metabolic acidosis | 1 0.01 40.86 Metabolic disorder | 1 0.01 40.87 Metastases to bone | 28 0.28 41.15 Metastases to lymph nodes | 1 0.01 41.16 Metastatic malignant melanoma | 17 0.17 41.33 Metastatic renal cell carcinoma | 8 0.08 41.41 Micturition disorder | 1 0.01 41.42 Migraine | 20 0.20 41.62 Mineral supplementation | 2 0.02 41.64 Mitral valve prolapse | 1 0.01 41.65 Mitral valve replacement | 1 0.01 41.66 Mood swings | 6 0.06 41.72 Movement disorder | 1 0.01 41.73 Muckle-Wells syndrome | 4 0.04 41.77 Mucopolysaccharidosis II | 1 0.01 41.78 Mucosal inflammation | 1 0.01 41.79 Mucous stools | 1 0.01 41.80 Multiple allergies | 16 0.16 41.96 Multiple gated acquisition scan | 1 0.01 41.97 Multiple sclerosis | 75 0.75 42.72 Multiple sclerosis relapse | 2 0.02 42.74 Muscle disorder | 2 0.02 42.76 Muscle relaxant therapy | 4 0.04 42.80 Muscle spasms | 6 0.06 42.86 Muscle spasticity | 20 0.20 43.06 Muscular dystrophy | 1 0.01 43.07 Musculoskeletal discomfort | 1 0.01 43.08 Musculoskeletal pain | 3 0.03 43.11 Musculoskeletal stiffness | 1 0.01 43.12 Myalgia | 4 0.04 43.16 Myelodysplastic syndrome | 18 0.18 43.34 Myelodysplastic syndrome transformation | 1 0.01 43.35 Myelofibrosis | 5 0.05 43.40 Myeloproliferative neoplasm | 1 0.01 43.41 Myocardial infarction | 11 0.11 43.52 Myocardial ischaemia | 8 0.08 43.60 Nail disorder | 1 0.01 43.61 Narcolepsy | 1 0.01 43.62 Nasopharyngitis | 10 0.10 43.72 Nausea | 26 0.26 43.98 Neck pain | 6 0.06 44.04 Neonatal respiratory distress syndrome | 1 0.01 44.05 Neoplasm | 1 0.01 44.06 Neoplasm malignant | 4 0.04 44.10 Neovascular age-related macular degen.. | 5 0.05 44.15 Nephrogenic anaemia | 1 0.01 44.16 Nephrolithiasis | 1 0.01 44.17 Nephrotic syndrome | 2 0.02 44.19 Nerve injury | 6 0.06 44.25 Nervous system disorder | 4 0.04 44.29 Nervousness | 1 0.01 44.30 Neuralgia | 17 0.17 44.47 Neuroblastoma | 6 0.06 44.53 Neuroblastoma recurrent | 3 0.03 44.56 Neuroendocrine carcinoma | 1 0.01 44.57 Neuroendocrine tumour | 2 0.02 44.59 Neuroleptic malignant syndrome | 2 0.02 44.61 Neuromyelitis optica spectrum disorder | 1 0.01 44.62 Neuropathy peripheral | 10 0.10 44.72 Nicotine dependence | 1 0.01 44.73 Niemann-Pick disease | 1 0.01 44.74 Non-Hodgkin's lymphoma | 14 0.14 44.88 Non-small cell lung cancer | 19 0.19 45.07 Non-small cell lung cancer metastatic | 1 0.01 45.08 Non-small cell lung cancer stage IIIB | 2 0.02 45.10 Nutritional supplementation | 3 0.03 45.13 Obliterative bronchiolitis | 1 0.01 45.14 Obsessive thoughts | 1 0.01 45.15 Obsessive-compulsive disorder | 5 0.05 45.20 Oedema | 5 0.05 45.25 Oedema peripheral | 1 0.01 45.26 Oesophageal candidiasis | 2 0.02 45.28 Oesophageal carcinoma | 1 0.01 45.29 Oesophageal disorder | 3 0.03 45.32 Oesophageal pain | 2 0.02 45.34 Oesophagitis | 1 0.01 45.35 Oestrogen replacement therapy | 1 0.01 45.36 Off label use | 1 0.01 45.37 Onychoclasis | 1 0.01 45.38 Onychomycosis | 1 0.01 45.39 Oppositional defiant disorder | 1 0.01 45.40 Oral candidiasis | 1 0.01 45.41 Oral contraception | 2 0.02 45.43 Oral herpes | 1 0.01 45.44 Oral pain | 2 0.02 45.46 Orthostatic hypertension | 1 0.01 45.47 Orthostatic hypotension | 1 0.01 45.48 Osteitis deformans | 1 0.01 45.49 Osteoarthritis | 7 0.07 45.56 Osteomyelitis | 2 0.02 45.58 Osteopenia | 50 0.50 46.08 Osteopetrosis | 1 0.01 46.09 Osteoporosis | 142 1.42 47.51 Osteoporosis postmenopausal | 3 0.03 47.54 Osteoporosis prophylaxis | 15 0.15 47.69 Osteosarcoma | 6 0.06 47.75 Otitis media | 3 0.03 47.78 Ovarian cancer | 13 0.13 47.91 Ovarian cancer recurrent | 3 0.03 47.94 Ovarian cyst | 3 0.03 47.97 Ovarian dysgerminoma stage unspecified | 2 0.02 47.99 Ovarian germ cell cancer | 6 0.06 48.05 Ovarian germ cell endodermal sinus tu.. | 3 0.03 48.08 Ovarian neoplasm | 3 0.03 48.11 Ovulation induction | 5 0.05 48.16 Pain | 127 1.27 49.43 Pain in extremity | 5 0.05 49.48 Pain management | 1 0.01 49.49 Pain prophylaxis | 1 0.01 49.50 Palpitations | 1 0.01 49.51 Pancreas transplant | 1 0.01 49.52 Pancreatic carcinoma | 6 0.06 49.58 Pancreatic neuroendocrine tumour | 2 0.02 49.60 Panic attack | 8 0.08 49.68 Panic disorder | 6 0.06 49.74 Panic reaction | 2 0.02 49.76 Paranoia | 1 0.01 49.77 Parathyroid disorder | 1 0.01 49.78 Parkinson's disease | 19 0.19 49.97 Parkinsonism | 1 0.01 49.98 Paronychia | 6 0.06 50.04 Paroxysmal nocturnal haemoglobinuria | 10 0.10 50.14 Pemphigus | 6 0.06 50.20 Pericardial effusion | 1 0.01 50.21 Peripheral arterial occlusive disease | 1 0.01 50.22 Peripheral swelling | 2 0.02 50.24 Peritoneal dialysis | 1 0.01 50.25 Persistent depressive disorder | 1 0.01 50.26 Personality disorder | 11 0.11 50.37 Petit mal epilepsy | 1 0.01 50.38 Pharyngeal disorder | 1 0.01 50.39 Pharyngitis | 1 0.01 50.40 Photodermatosis | 1 0.01 50.41 Phytotherapy | 1 0.01 50.42 Pituitary hypoplasia | 1 0.01 50.43 Pituitary tumour benign | 1 0.01 50.44 Pituitary-dependent Cushing's syndrome | 1 0.01 50.45 Pityriasis | 3 0.03 50.48 Plantar fasciitis | 1 0.01 50.49 Plasma cell myeloma | 32 0.32 50.81 Platelet aggregation inhibition | 1 0.01 50.82 Platelet count decreased | 1 0.01 50.83 Platelet count increased | 1 0.01 50.84 Pleural effusion | 1 0.01 50.85 Pleural mesothelioma | 2 0.02 50.87 Pneumococcal immunisation | 1 0.01 50.88 Pneumonia | 8 0.08 50.96 Pneumonia staphylococcal | 1 0.01 50.97 Polycystic ovaries | 15 0.15 51.12 Portal hypertension | 1 0.01 51.13 Post herpetic neuralgia | 1 0.01 51.14 Post-traumatic stress disorder | 4 0.04 51.18 Postmenopause | 2 0.02 51.20 Pregnancy | 5 0.05 51.25 Premedication | 49 0.49 51.74 Premenstrual dysphoric disorder | 4 0.04 51.78 Premenstrual syndrome | 8 0.08 51.86 Prenatal care | 1 0.01 51.87 Preoperative care | 2 0.02 51.89 Primary hypothyroidism | 1 0.01 51.90 Product used for unknown indication | 3,215 32.15 84.05 Productive cough | 1 0.01 84.06 Prophylactic chemotherapy | 1 0.01 84.07 Prophylaxis | 156 1.56 85.63 Prophylaxis against gastrointestinal .. | 7 0.07 85.70 Prophylaxis against graft versus host.. | 5 0.05 85.75 Prophylaxis against transplant reject.. | 3 0.03 85.78 Prophylaxis of nausea and vomiting | 7 0.07 85.85 Prophylaxis of neural tube defect | 1 0.01 85.86 Prophylaxis urinary tract infection | 2 0.02 85.88 Prostate cancer | 9 0.09 85.97 Prostate cancer metastatic | 9 0.09 86.06 Prostatic adenoma | 1 0.01 86.07 Prostatic disorder | 1 0.01 86.08 Prostatitis | 1 0.01 86.09 Prostatomegaly | 2 0.02 86.11 Protein-losing gastroenteropathy | 6 0.06 86.17 Pruritus | 8 0.08 86.25 Psoriasis | 50 0.50 86.75 Psoriatic arthropathy | 45 0.45 87.20 Psychiatric decompensation | 1 0.01 87.21 Psychotic disorder | 51 0.51 87.72 Pulmonary arterial hypertension | 35 0.35 88.07 Pulmonary embolism | 5 0.05 88.12 Pulmonary fibrosis | 1 0.01 88.13 Pulmonary hypertension | 13 0.13 88.26 Pulmonary sarcoidosis | 5 0.05 88.31 Pulmonary thrombosis | 2 0.02 88.33 Pulmonary tuberculosis | 1 0.01 88.34 Pyelonephritis | 5 0.05 88.39 Pyelonephritis acute | 1 0.01 88.40 Pyrexia | 5 0.05 88.45 Rash | 3 0.03 88.48 Rectal cancer | 5 0.05 88.53 Rectal cancer metastatic | 16 0.16 88.69 Reflux gastritis | 1 0.01 88.70 Relapsing-remitting multiple sclerosis | 8 0.08 88.78 Relaxation therapy | 2 0.02 88.80 Renal cell carcinoma | 8 0.08 88.88 Renal colic | 1 0.01 88.89 Renal disorder | 7 0.07 88.96 Renal failure | 2 0.02 88.98 Renal haemorrhage | 1 0.01 88.99 Renal transplant | 12 0.12 89.11 Respiratory disorder | 2 0.02 89.13 Respiratory tract infection | 2 0.02 89.15 Restless legs syndrome | 5 0.05 89.20 Restlessness | 4 0.04 89.24 Retinal vein occlusion | 2 0.02 89.26 Retroviral infection | 2 0.02 89.28 Rhabdomyosarcoma | 6 0.06 89.34 Rheumatic disorder | 1 0.01 89.35 Rheumatoid arthritis | 398 3.98 93.33 Rhinitis allergic | 5 0.05 93.38 Rhinitis perennial | 1 0.01 93.39 Routine health maintenance | 3 0.03 93.42 SLE arthritis | 1 0.01 93.43 Sacroiliitis | 2 0.02 93.45 Sarcoidosis | 1 0.01 93.46 Sarcoma | 1 0.01 93.47 Schizoaffective disorder | 20 0.20 93.67 Schizophrenia | 137 1.37 95.04 Sciatic nerve neuropathy | 3 0.03 95.07 Sciatica | 2 0.02 95.09 Scleroderma | 1 0.01 95.10 Screaming | 1 0.01 95.11 Scrotal cyst | 2 0.02 95.13 Seasonal allergy | 13 0.13 95.26 Secondary amyloidosis | 1 0.01 95.27 Sedation | 8 0.08 95.35 Seizure | 42 0.42 95.77 Sepsis | 2 0.02 95.79 Sickle cell anaemia | 5 0.05 95.84 Sinus disorder | 1 0.01 95.85 Sinusitis | 6 0.06 95.91 Sinusitis bacterial | 1 0.01 95.92 Sjogren's syndrome | 2 0.02 95.94 Skeletal injury | 3 0.03 95.97 Skin exfoliation | 2 0.02 95.99 Skin wrinkling | 1 0.01 96.00 Sleep apnoea syndrome | 2 0.02 96.02 Sleep disorder | 29 0.29 96.31 Sleep disorder therapy | 2 0.02 96.33 Small cell lung cancer | 2 0.02 96.35 Small cell lung cancer extensive stage | 1 0.01 96.36 Small for dates baby | 2 0.02 96.38 Small intestine carcinoma | 1 0.01 96.39 Smoking cessation therapy | 4 0.04 96.43 Speech disorder | 1 0.01 96.44 Spinal anaesthesia | 1 0.01 96.45 Spinal column stenosis | 4 0.04 96.49 Spinal myelogram | 1 0.01 96.50 Spinal pain | 1 0.01 96.51 Spondylitis | 1 0.01 96.52 Sputum purulent | 1 0.01 96.53 Squamous cell carcinoma | 2 0.02 96.55 Staphylococcal infection | 1 0.01 96.56 Stem cell transplant | 3 0.03 96.59 Stent placement | 6 0.06 96.65 Steroid therapy | 1 0.01 96.66 Steroid withdrawal syndrome | 1 0.01 96.67 Stomatitis | 5 0.05 96.72 Stress ulcer | 1 0.01 96.73 Stress urinary incontinence | 1 0.01 96.74 Subcutaneous abscess | 1 0.01 96.75 Superinfection | 2 0.02 96.77 Supplementation therapy | 12 0.12 96.89 Swelling | 2 0.02 96.91 Systemic lupus erythematosus | 7 0.07 96.98 Tachycardia | 3 0.03 97.01 Teratoma | 3 0.03 97.04 Testis cancer | 5 0.05 97.09 Thalassaemia | 1 0.01 97.10 Thalassaemia beta | 1 0.01 97.11 Threatened labour | 5 0.05 97.16 Thrombocytosis | 1 0.01 97.17 Thrombosis | 4 0.04 97.21 Thrombosis in device | 1 0.01 97.22 Thrombosis prophylaxis | 11 0.11 97.33 Thyroid cancer | 10 0.10 97.43 Thyroid disorder | 36 0.36 97.79 Thyroidectomy | 1 0.01 97.80 Thyroiditis subacute | 1 0.01 97.81 Tooth abscess | 1 0.01 97.82 Tooth infection | 1 0.01 97.83 Torticollis | 3 0.03 97.86 Transient ischaemic attack | 1 0.01 97.87 Transitional cell carcinoma | 13 0.13 98.00 Tremor | 2 0.02 98.02 Trigeminal neuralgia | 2 0.02 98.04 Tuberculosis | 7 0.07 98.11 Tumour lysis syndrome | 1 0.01 98.12 Type 1 diabetes mellitus | 8 0.08 98.20 Type 2 diabetes mellitus | 103 1.03 99.23 Ubiquinone | 1 0.01 99.24 Ulcer | 2 0.02 99.26 Ulcer haemorrhage | 4 0.04 99.30 Upper respiratory tract infection | 5 0.05 99.35 Urinary incontinence | 2 0.02 99.37 Urinary tract discomfort | 1 0.01 99.38 Urinary tract disorder | 1 0.01 99.39 Urinary tract infection | 5 0.05 99.44 Urticaria | 1 0.01 99.45 Uveitis | 1 0.01 99.46 Vaginal haemorrhage | 2 0.02 99.48 Vaginal infection | 1 0.01 99.49 Venous thrombosis | 1 0.01 99.50 Ventricular tachycardia | 2 0.02 99.52 Vertebral artery dissection | 1 0.01 99.53 Viral infection | 10 0.10 99.63 Visual impairment | 2 0.02 99.65 Vitamin B12 abnormal | 1 0.01 99.66 Vitamin D decreased | 1 0.01 99.67 Vitamin D deficiency | 6 0.06 99.73 Vitamin K deficiency | 2 0.02 99.75 Vitamin supplementation | 7 0.07 99.82 Vogt-Koyanagi-Harada syndrome | 1 0.01 99.83 Vomiting | 8 0.08 99.91 Vulvovaginal candidiasis | 1 0.01 99.92 Weight control | 1 0.01 99.93 Weight decreased | 1 0.01 99.94 Wheezing | 3 0.03 99.97 White blood cell count abnormal | 1 0.01 99.98 Wound treatment | 1 0.01 99.99 X-ray | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 6 Apr 2017